These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32373607)

  • 61.
    Li Z; Langhans SA
    Front Oncol; 2021; 11():620831. PubMed ID: 33869004
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neural Lineage Differentiation From Pluripotent Stem Cells to Mimic Human Brain Tissues.
    Hong YJ; Do JT
    Front Bioeng Biotechnol; 2019; 7():400. PubMed ID: 31867324
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Importance of organoids for personalized medicine.
    Perkhofer L; Frappart PO; Müller M; Kleger A
    Per Med; 2018 Nov; 15(6):461-465. PubMed ID: 30418092
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Non-animal glioblastoma models for personalized treatment.
    Zottel A; Jovčevska I; Šamec N
    Heliyon; 2023 Oct; 9(10):e21070. PubMed ID: 37928397
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Organoid Models of Glioblastoma and Their Role in Drug Discovery.
    Rybin MJ; Ivan ME; Ayad NG; Zeier Z
    Front Cell Neurosci; 2021; 15():605255. PubMed ID: 33613198
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Patient-derived cell line, xenograft and organoid models in lung cancer therapy.
    Huo KG; D'Arcangelo E; Tsao MS
    Transl Lung Cancer Res; 2020 Oct; 9(5):2214-2232. PubMed ID: 33209645
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New Advances in the Study of Bone Tumors: A Lesson From the 3D Environment.
    Cortini M; Baldini N; Avnet S
    Front Physiol; 2019; 10():814. PubMed ID: 31316395
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cancer Stem Cells and Glioblastoma: Time for Innovative Biomarkers of Radio-Resistance?
    Pasqualetti F; Miniati M; Gonnelli A; Gadducci G; Giannini N; Palagini L; Mancino M; Fuentes T; Paiar F
    Biology (Basel); 2023 Sep; 12(10):. PubMed ID: 37887005
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preclinical Cancer Models and Biomarkers for Drug Development: New Technologies and Emerging Tools.
    Dhandapani M; Goldman A
    J Mol Biomark Diagn; 2017 Sep; 8(5):. PubMed ID: 29285415
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-Term Culture of Intestinal Cell Progenitors: An Overview of Their Development, Application, and Associated Technologies.
    Hollins AJ; Parry L
    Curr Pathobiol Rep; 2016; 4(4):209-219. PubMed ID: 27882268
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rapid Processing and Drug Evaluation in Glioblastoma Patient-Derived Organoid Models with 4D Bioprinted Arrays.
    Chadwick M; Yang C; Liu L; Gamboa CM; Jara K; Lee H; Sabaawy HE
    iScience; 2020 Aug; 23(8):101365. PubMed ID: 32731171
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Practical Review on Preclinical Human
    Soubéran A; Tchoghandjian A
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825103
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Human Plasma-Derived 3D Cultures Model Breast Cancer Treatment Responses and Predict Clinically Effective Drug Treatment Concentrations.
    Calar K; Plesselova S; Bhattacharya S; Jorgensen M; de la Puente P
    Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32610529
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Organotypic Models to Study Human Glioblastoma: Studying the Beast in Its Ecosystem.
    Pamies D; Zurich MG; Hartung T
    iScience; 2020 Oct; 23(10):101633. PubMed ID: 33103073
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Organoid research in digestive system tumors.
    Yang X; Xu X; Zhu H; Wang M; Wang D
    Oncol Lett; 2021 Apr; 21(4):308. PubMed ID: 33732384
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Toward improved
    Ayuso JM; Park KY; Virumbrales-Muñoz M; Beebe DJ
    APL Bioeng; 2021 Mar; 5(1):010902. PubMed ID: 33532672
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The 'Ins and Outs' of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong?
    Rominiyi O; Al-Tamimi Y; Collis SJ
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30934632
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Personalized in vitro cancer modeling - fantasy or reality?
    Bartlett R; Everett W; Lim S; G N; Loizidou M; Jell G; Tan A; Seifalian AM
    Transl Oncol; 2014 Dec; 7(6):657-64. PubMed ID: 25500073
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modeling Brain Tumors: A Perspective Overview of
    Antonica F; Aiello G; Soldano A; Abballe L; Miele E; Tiberi L
    Front Mol Neurosci; 2022; 15():818696. PubMed ID: 35706426
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Organoid models of glioblastoma: advances, applications and challenges.
    Zhang C; Jin M; Zhao J; Chen J; Jin W
    Am J Cancer Res; 2020; 10(8):2242-2257. PubMed ID: 32905502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.